Precision breast oncology: molecular insights and transformative clinical strategies

Cancer Treatment and Research Communications 2026 Open access

Read full text
Authors: Bhoovi Chauhan, Dinesh Kumar, Anas Ahmad, Ziyaul Haque, Mirza Salman Baig, Neeraj Choudhary, Rajni Tanwar, A. Sophia, Mohammad Intakhab Alam, Thomas J. Webster, Md. Faiyazuddin
DOI: 10.1016/j.ctarc.2026.101242
Cited by: 1
References: 238

Abstract

• Breast cancer (∼2.3M cases; ∼665,000-670,000 deaths annually) demands molecularly stratified, precision-first clinical paradigms. • Subtype-resolved therapeutics (Luminal A/B, HER2+, TNBC) deliver >90% 5-year survival in early disease, yet

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Cancer Cells and Metastasis Cancer Research and Treatments

Publication details

Journal / source
Cancer Treatment and Research Communications
Publisher
Elsevier BV
Volume
47
Pages
101242–101242
Publication date
1 January 2026
Language
EN